MedTrace Logo

Study of Lymphoma in Asia

NCT01584141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13433

Last updated 2020-11-27

No results posted yet for this study

Summary

Background:

\- Lymphoma rates in Asia have been lower than in the West, but rates have been rising in recent years. Most studies of lymphoma patients have been conducted in the West. Less information is available about the factors that might contribute to the rise of lymphoma in Asia. Researchers want to collect medical and personal histories and samples from people who have recently been diagnosed with lymphoma. This information will help them study possible reasons for this increase.

Objectives:

\- To collect samples and histories as part of an introductory study of lymphoma in Asia.

Eligibility:

* People between 18 and 79 years of age who have entered study hospitals in Hong Kong, Taiwan, and mainland China for treatment for any type of lymphoma.
* Healthy volunteers between 18 and 79 who have never had lymphoma.

Design:

* Participants will be screened with a physical exam and medical history.
* They will provide blood samples and cheek cell samples for testing.
* Participants will complete a questionnaire about their personal health history. They will answer questions about exposures to chemicals like pesticides. They will also be asked about family medical history and work and residential history. Finally they will answer questions about lifestyle factors like diet and exercise.
* They will give permission for the researchers to see their medical records. Researchers will also have access to any tumor samples collected as part of treatment.

Conditions

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Qing Lan, M.D. · National Cancer Institute (NCI)

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-05
Primary Completion
2018-07-10
Completion
2018-07-10

Countries

  • China
  • Hong Kong
  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01584141 on ClinicalTrials.gov